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DNA flow cytometry has shown a wider spectrum of 
DNA content in the complete hydatidiform mole 
(CM) than the originally reported diploidy. Conflict­
ing results have been published about the relation­
ship o f DNA content and the occurrence of persis­
tent gestational trophoblastic disease (PGTD). In 
the present study, 71 cases of CM and 4 cases of 
partial mole accompanied by PGTD and 100 cases 
of CM without PGTD were evaluated with DNA im­
age cytometry for differences in DNA-ploidy pat­
tern, expressed as the 2.5c and 5c exceeding rates. A 
pilot study of 20 cases of each group was performed 
using interphase cytogenetics to detect differences 
in  the frequency of numerical chromosomal aber­
rations and in sex chromosome composition. For 
this purpose, DNA probes specific for the pericen- 
trom eric regions of chromosomes 1 and X and for 
the long arm of chromosome Y were incubated on 
6-/utm paraffin tissue sections. The results showed 
no differences between CMs with or without PGTD; 
DNA polyploidy occurred in 99% and 98% of cases, 
respectively; the 2.5c exceeding rate and 5c exceed­
ing rate were 62.6 and 62.4, and 6.5 and 6.0, respec­
tively. The frequency of numerical chromosomal 
aberrations as detected by interphase cytogenetics 
was 23.4 and 22.8%. An XY pattern was found in 3 of 
20 cases of CM with PGTD and in 4 of 20 cases of CM 
without PGTD. The four cases of partial mole 
showed a DNA-ploidy pattern identical to that of a 
CM. For this reason, they would be better reclassi­
fied as CMs, despite the presence of nucleated red 
blood cells or amnion. Although nuclear atypia and
0893-3952/96/09010-1007$3.00/0 MODERN PATHOLOGY 
Copyright © 1996 by The United States and Canadian Academy of 
Pathology, Inc.
VOL. 9, NO. 10, P. 1007, 1996 Printed in the U.S.A.
Date of acceptance: July 1, 1996.
Address reprint requests to: Christina A. van de Kaa, M.D., Institute of 
Pathology, University Hospital Nijmegen, Post Office Box 9101, 6500 HB 
Nijmegen, The Netherlands; fax: 31-24-3540520.
corresponding increased DNA content is pro­
nounced but variable in CMs, the occurrence of 
PGTD is not related to variations in quantitative 
DNA content nor to gross heterology or homology in 
sex chromosomes.
KEY WORDS: DNA ploidy, Hydatidiform mole, Im­
age cytometry, In situ hybridization, Persistent tro­
phoblastic disease.
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Persistent gestational trophoblastic disease (PGTD) 
requiring chemotherapy develops in 10 to 20% of 
patients with a complete hydatidiform mole (CM) 
(1, 2). Choriocarcinoma is included in this group. 
Before current chemotherapy regimens and /3-hu­
man chorionic gonadotropin Q3-hCG) monitoring, 
choriocarcinoma was diagnosed in 2 to 19% of pa­
tients with a CM; 50% of gestational choriocarcino­
mas were preceded by a CM, the other 50% by 
abortions or normal pregnancies (3, 4). Today, a 
diagnosis of postmolar choriocarcinoma is rarely 
made, because PGTD is detected early as a result of 
/3-hCG monitoring (2), which makes re-evacuations 
for a histologic confirmation of choriocarcinoma 
unnecessary. If treated promptly, the prognosis of 
postmolar PGTD, including choriocarcinoma, is ex­
cellent, with an overall survival rate of more than 
90% (5). The risk of PGTD after a partial mole (PM) 
is less established as compared with a CM, but it 
has been estimated to occur in 0.5% of patients 
with PM (6). It is recommended that patients with a 
CM and those with a PM be given the same clinical 
follow-up, with regular /3-hCG assays and the post­
ponement of pregnancy.
For pathologists, the histologic distinction be­
tween a CM and a PM and their differentiation from 
hydropic abortion is not always easy. To assess 
prognostic and therapeutic implications in the in­
dividual patient, it is important that the pathologic
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classification is as accurate as possible. Previous 
studies (7, 8) using karyotyping delineated the 
pathologic and cytogenetic differences between 
these entities. CMs have a diploid karyotype, with 
the entire nuclear genome being derived from the 
father (9). PMs are triploid, with one maternally and 
two paternally derived sets of DNA (1). Hydxopic 
abortions usually have an overall diploid DNA but 
with a variety of individual chromosomal aberra­
tions .
As a powerful aid in the differential diagnosis, 
DNA flow cytometric analysis is now widely being 
used. In comparison with karyotyping, however, 
DNA flow cytometric studies show a wider spec­
trum of nuclear DNA in CMs then the previously 
detected diploidy (10-14). A higher incidence of 
PGTD was initially reported in DNA-aneuploid CMs 
(15), but this has not yet been confirmed by other 
studies (11, 13, 16). In all studies, DNA flow cyto­
metric analysis was the applied technique. In one 
previous study (12), however, it was found that in 
the detection of cell subpopulations with increased 
DNA content, DNA flow cytometric analysis is less 
sensitive than DNA image cytometric analysis 
(ICM) and interphase cytogenetic analysis. Using 
interphase cytogenetic analysis, one could establish 
that the aberrant cell subpopulations with high 
DNA content (polyploidization) were mainly lo­
cated in the extravillous trophoblast, with the cho­
rionic villi being uniformly diploid.
In this study, DNA ICM was applied to 175 cases 
of hydatidiform mole, and interphase cytogenetic 
analysis was applied to a subgroup of 44 of the 175 
cases for additional evaluation of the DNA ploidy 
and numerical chromosomal aberrations in extra­
villous trophoblast, with special interest in differ­
ences that could predict PGTD. For this purpose, 
the parameters were (1) the ratio of the cell sub­
populations with increased DNA content to the 
DNA-diploid cell population, expressed as the 2.5c 
and 5c exceeding rates (ERs) using DNA ICM; and 
(2) the degree of numerical chromosomal aberra­
tions in the cell subpopulation with increased DNA 
content using interphase cytogenetic analysis.
MATERIAL AND METHODS
Patients
For this study, 75 cases of hydatidiform mole (71 
cases of CM and 4 cases of PM) that were accom­
panied by PGTD were compared with 100 cases of 
CMs without PGTD. The cases were obtained from 
the files of the Central Molar Registration of The 
Netherlands at the University Hospital of Nijmegen, 
Nijmegen, The Netherlands, which provides na­
tional registration of hydatidiform moles and PGTD 
and supraregional laboratory service for j8-hCG
monitoring, and from the files of The Netherlands 
Study Group of Trophoblastic Tumors, in which 
discussions and decision making concerning fol­
low-up and treatment take place at a national level. 
Clinical follow-up after molar evacuation included 
serum 0-hCG titers measured weekly until normal 
for 3 consecutive weeks and then monthly for 1 
year. PGTD was diagnosed when /3-hCG levels per­
sisted at a plateau and/or rose for at least 3 consec­
utive weeks. The cases of hydatidiform mole with 
PGTD were selected on the occurrence of PGTD 
irrespective of the initial or review diagnosis. The 
cases of hydatidiform mole without PGTD were 
selected on the review diagnosis of CM. From all of 
the cases, the histologic slides were reviewed ac­
cording to the criteria of Szulman and Surti (7, 8) 
before the DNA analyses.
DNA ICM
DNA ICM was performed on all of the cases, as 
previously described (12). Briefly, intact nuclei were 
isolated from 5 0 - /x m -thick paraffin tissue sections. 
Maternal decidual tissue was processed separately 
and served as the internal control for normal dip­
loid cells. If decidual cells were not available, ma­
ternal lymphocytes were used as the alternative. 
After deparaffinization and rehydration, the 50-/xm 
sections were incubated with 0.1% protease (type 
VII Bacillus amyloliquefaciens; Sigma, St. Louis, 
MO) in phosphate buffered saline (PBS) at 37°C for 
20 minutes. Incubation was terminated by adding 4 
to 5 ml of cold (4°C) PBS and putting the tubes on 
ice. After rinsing with PBS, 30,000 nuclei were 
counted with a Coulter Counter Model ZB1 (Coulter 
Electronics, Dunstable, England). After centrifuga­
tion, 200 ¡A of fetal calf serum (Gibco, Paisley, Scot­
land) were added, and this nuclear suspension was 
centrifuged to a glass slide using a cytocentrifuge 
for 10 minutes at 500 rpm (Shandon, Zeist, The 
Netherlands), air dried, and fixed in a mixture of 
methanol, 37% formaldehyde, and acetic acid (85: 
10:5 by volume) for 1 hour. The nuclei were then 
stained with pararosaniline-Feulgen. The DNA con­
tent of 200 stained and intact nuclei of trophoblast 
cells were selectively measured using the CAS 100 
System (Cellular Imaging Systems, Becton Dickin­
son, Leiden, The Netherlands) (17). Leukocytes and 
decidual cells were not measured as diagnostic 
cells. At least 30 rat liver cells (DNA tetraploid) were 
measured as an external control for DNA content, 
and at least 20 decidual cells were used as an inter­
nal control.
The DNA histograms were classified as follows. A 
DNA-diploid pattern consisted of a distinct G0/G, 
peak in the diploid (2C; DNA index (DI) = 1.0 ± 0.1) 
region with a small proportion of cells in S and 
G2/M (4C) phases, defined by a 2.5c ER of less then
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40% (12). A DNA-polyploid pattern showed distinct 
peaks in the diploid (2C; DI = 1.0 ± 0.1) and tet- 
raploid (4C; DI = 2.0 ± 0.2) regions with a 2.5c ER 
of 40% or more, or in the diploid, tetraploid, and 
octaploid (8C; DI = 4.0 ± 0.4) regions. The 2.5c ER 
and the 5c ER were determined from the nuclear 
fractions exceeding the first 2c G0/Gx peak with a DI 
greater than 1.25 and the 4c peak with a DI greater 
than 2.5, respectively. A 2.5c ER of 40% or more 
seem ed to be a reliable parameter for discrimina­
tion between DNA diploidy and DNA polyploidy 
(12).
Interphase Cytogenetic Analysis
Interphase cytogenetic analysis was performed 
on 6-ju.m-thick paraffin-embedded tissue sections 
in 44 of the 175 cases: 20 cases of CM with PGTD, all
4 o f the cases of PM with PGTD, and 20 cases of CM 
without PGTD. The chromosome-specific DNA 
probes used were the satellite III DNA probe for 
chromosome 1 (pUC 1.77), the alphoid DNA probe 
for chromosome X (pBam X5), and the satellite III 
DNA probe for chromosome Y (DYZ3), recognizing 
tandem  repeats in the pericentromeric region 
(lq l2 ) of chromosome 1 (18), in the centromeric 
region of chromosome X (19), and in the q arm of 
chromosome Y (20), respectively. Biotinylation of 
th e probes was performed using Bio-14-dATP (BRL, 
Gaithersburg, MD), according to the instructions of 
th e manufacturers. The in situ hybridization proce­
dure (ISH) in paraffin-embedded tissue sections 
w as performed as previously described (12, 21), 
w ith minor modifications in the immunohisto- 
chem ical step: mouse anti-biotin (1:100 in PBS- 
Tw een with 5% nonfat dry milk; Dakopatts, 
Glostrup, Denmark) was followed by biotin-labeled 
horse anti-mouse (1:200 in PBS-Tween, 5% nonfat 
dry milk; Vector, Burlingame, CA), and avidin-bi- 
otin  complex (1:100 in PBS-Tween, 5% nonfat dry 
milk; Vector). The frequency of ISH signals for the 
different chromosomes was evaluated in at least 
500 nuclei according to previously reported criteria 
(12, 21).
Statistical Analysis
The mutual differences in the 2.5c ER and 5c ER 
as well as in the chromosome copy numbers be­
tween the group of CMs with PGTD and the group 




The initial diagnoses given by the referring pa­
thologists are listed in Table 1 and compared with 
the revised diagnoses. Excluding the cases in which 
no initial diagnosis was made, the interobserver 
variability was 26% and 35% for the groups of hy- 
datidiform moles with PGTD and without PGTD, 
respectively. The four cases of PM with PGTD were 
remarkable in that the histomorphologic character­
istics of the chorionic villi and the degree of tropho­
blastic hyperplasia were identical to those found in 
the CMs, but focal vital nucleated red blood cells 
(NRBCs) within capillaries of molar villi, amnion, or 
yolk sac structures could be found (Fig. 1), because 
of which the cases were formerly classified as PM. 
In CMs, nonfunctional capillaries were often found 
within the villous stroma. They contained nuclear 
and cellular debris, and pericapillary hemosiderin 
deposits could sometimes be found when an iron 
stain was performed (Fig. 2). The presence of NR­
BCs is unusual, however, in these ill-formed stro­
mal vessels of otherwise unequivocally molar villi 
with stromal karyorrhexis and atypical trophoblast 
hyperplasia. Twin gestation was unlikely on the 
basis of the histomorphologic characteristics (the 
absence of normal villi, the presence of NRBCs in 
molar villi) and the results of interphase cytogenetic 
analyses. The mean age of the patients was similar 
in both groups (30 yr), as was the mean duration of 
pregnancy (12 wk).
DNA ICM
In all of the cases, a satisfactory DNA histogram 
was obtained, except in one case of a CM without
TABLE 1 .  C om parison  of Initial Histologic D iag n o sis  of t h e  Referring P a th o lo g is t  w ith  t h e  R evised  H isto logic  
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Initial diagnosis













Complete mole 12 57 25 6 — 100
Moles with PGTD
Complete mole 5 50 14 1 1 71
Partial mole — 1 2 1 — 4
PGTD, persistent gestational trophoblastic disease.
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FIGURE 3. DNA ICM of a CM showing DNA polyploidy. The DNA- 
diploid [arrow at D1 = 1), DNA-tetraploid (airow at D1 = 2), and DNA- 
octaplold (arrow at DI = 4) peaks represent different nuclear fractions 
of the m olar tissue.
D N A  — I n d e x  h is t o g r a m  inherent to molar trophoblast and because tumor
aggressiveness in general correlates with increase in 
nuclear atypia and DNA content, it seemed logical 
to explore the predictive value of histologic grade 
and DNA content in CMs.
Histologic grade, assessed on the basis of degree 
of trophoblastic hyperplasia and atypia, had al­
ready been suggested to have prognostic signifi­
cance by Hertig and Sheldon (22) in a six-group 
grading system and by Hertig and Mansell (3) in a 
more reproducible three-group grading system. Al­
though some studies (23, 24) initially supported 
these findings, others could not (25, 3), and finally, 
the grading system has been abandoned.
DNA content had been related to progressive dis­
ease by Sugimori et a l  (26), using microspectro- 
photometric analysis, which demonstrated a subse­
quent increase of DNA content in CMs without and 
with progression toward destructive mole and in 
choriocarcinoma. Sugimori et a l  (26) also found a 
correlation between higher and more widely dis­
tributed DNA content and delayed /3-hCG regres­
sion curves. Using DNA flow cytometric techniques, 
Martin et al (15) also found a positive correlation 
between DNA content and the development of 
PGTD. PGTD developed in 45% of their series of 40 
patients, involving 77% of aneuploid cases and only 
30% of euploid cases. The correlation of clinical 
course with ploidy was significant (P < 0.01). No 
association was found with proliferative (mitotic) 
index (P> 0.05). Other studies (11,13,16), however, 
have not confirmed these findings. Hemming et al 
(16) noticed a relatively high tetraploid DNA peak in 
most CMs, which they interpretated as a high pro­
liferative fraction but which more likely represents 
the extravillous trophoblast with increased 
polyploidization (12)); Hemming et a l (16) could 
not detect a correlation between this fraction and 
not found with either method. The chorionic villi the occurrence of PGTD. Lage et a l (11) and Fuku- 
showed the same sex chromosomal composition as naga et al (13) found a relatively high frequency of 
the NRBCs, amnion, or yolk sac (Fig. 5). Statistical DNA-tetraploid CMs, but there was no increased 
analysis showed no significant correlation between incidence of PGTD in these cases as compared with
TABLE 2. 2.5c  and 5c E xceeding  Rates (%) in 
H y d a t id i f o r m  Moles With a n d  W ith o u t P e rs is te n t  
G e s ta t io n a l  Trophoblastic D isease
Exceeding rates








Complete mole Partial mole Complete mole
Total N 71 4 99
2.5c Exceeding rate:
Mean 62.6 60.0 62.4
Standard deviation 11.2 11.2 12.1
Range 31.5-89.0 48,0-77.9 28.0-86.9
5c Exceeding rate:
Mean 6.5 5.4 6.0
Standard deviation 6.3 2.8 6.4
Range 0-32.5 1.3-8.5 0-38.3
the 2.5 c ER using ICM and the polysomic nuclear 
fraction using ISH.
their group of DNA-diploid CMs.
All of these studies were based on DNA flow 
cytometric analysis. A previous study (12), however, 
found that DNA flow cytometric analysis is less 
sensitive than DNA ICM and interphase cytogenetic 
PGTD develops in only a minority of patients analysis in the detection of aberrant cell subpopu- 
with a hydatidiform mole. The lack of a reliable lations with increased DNA content. Using inter-
DISCUSSION
predictor of PGTD, however, necessitates clinical 
follow-up in all patients. Nevertheless, the pathol­
ogist must distinguish the low-risk (0.5%) PM from 
the high-risk (10-20%) CM. The degree of nuclear 
atypia and the DNA content of the extravillous tro- (14). Therefore, in the present study, both of these 
phoblast are significantly higher in CMs than in techniques were used for additional evaluation of 
PMs (12), but considerable variability also exists the variability in DNA content in CMs and the pos-
phase cytogenetic methods, we demonstrated that 
chorionic villi in CMs are always diploid, whereas 
the extravillous trophoblast shows extensive 
polyploidization. Others confirmed this finding
within CMs. Because the potential for malignant 
progression in hydatidiform moles is thought to be
sible relation to PGTD. Using DNA ICM, however, 
no such correlation could be found: almost all of
DNA in P e r s i s t e n t  T r o p h o b la s t ic  D is e a s e  (C.A. v a n  d e  Kaa e t  al.) 1011
TABLE 3. O vera ll Results of In terphase Cytogenetic A nalysis ln Extravillous Trophob last of H yd atld ifo rm  SVSoles W ith
and W ith o u t Persistent G esta tio n a l Trophoblastic D isease
-i Tr--|->iiwrrrfi^ ir^ f-rfii)-ij j 'r tr t " 1T m ì i>vriVi-iVinni:tiì<iy'iMi ..................................................... i» |in ji/- ff :tr , 1-lrTTi-rTn^JV:l" t-,j>- ^ ì- r i J,‘M**l‘..........................1'................ ..............................................................................................................  ■ - ■ — ' ' ' a ^ — im iiM iiiM iiiiii i ■ I iinMMMrtiHnvnnirfflMirt............. - ■rtt'iWWWfci-rnr i n  ............................. »im a n ii i»n i ii"nwMifwi»tw lf i i HNJitniTrr n r t fH'~ n-fifiTnmiTi>-rnirfini riH------YnnnTnritm------ iiwriTr—frrt................
Total (.N)
Percentage of nuclei with in
i n ; « )
i irr > • nrrriWiiii»  HTj-n r r ' - 'rfiim iiì if*» m .u n !iii" ii  in rn li i n  i d i 1 1 il il ir....... rrjiir r i iij i in o lili' f i  n.i. n y r  j *ii> i u j  ■ n >,«j mt~~i-------T f ~ r hi », i  in ,n ii no  w tw  turn wBwwJjj!
<2 (mean - + • SD) SD)
tPWfl«xn lì  ¡M.i n i-iilmiii<ininiii,iiii-iii'iii> HÉiiiiìr iiiriit i. i i i ' ^ T i ir n  ni i i i tn i! jiin.»i .lrr,T n T n i r i" i , r r ii TTn- r ,n m iu i r r r - T ....... n ‘'“ '■s- r ,- r Jr r i r - T- r r r - | ,Tr r r ~— ‘“ f  *1...............................................................................m i n 1-------rrn  if " " -......... ........................................... ..... - ".i inm:
Complete mole without PGTD 20 4:16 77.1 ± 7,8 22.8 ± 7.8
Complete mole with PGTD 20 3:17 76.6 ± 8.3 23.4 ± 8.7
Partial mole with PGTD 4 2:2 80.1 ± 10.3 19.8 ± 10.3
w # t r i r j m n f ï ï i ] i F j i r r . i v [ f j i t i i w r i r i i i i ^ r iTfYiirw in rrt riiri w f ■ to Mirff ü w r< l'unii mîtî iftïffiminfmninrfrri mrwm írm ryrr nnf f ^  Trn r^i nfínniniif








>m»j i 01 li i nl*lil*n»w nw  l«W >u
•’■vta
-W(UVWih 5 (mean SD)
o Q O AZ .o  JL Z ,4
3.2 •W/14i«** 3.6
h fcw fi» hi rt w BJ1 < rMirrnrn'ji i i[<nu tm ¡ r a uarwis ¡utro if/jiBOiü i i»nww^wi<waifí v< w wi^i m m i< *âmif w ^  ii wf di ké» tiuwMwwìut »» w ^ iw >r*f »iw t j »mwu» W y jiiraiN
TABLE 4. M ean Spectrum  of In Situ Hybridization S ig n a ls  per N u cleu s in Extravillous Trophoblast of Hydatidiforir» 
M oles W ith and W ithout P ersisten t G estational T rophoblastic D ise a se
Interphase cytogenetic analysis of nuclei with in situ signals
!Wim M imin ijii!«iiiiiH ji iT‘:':::nurrTr.riT.ii;.i.r.i. iinn iirivijij.<iiii^ifr i '- | f r i i r r nTnriiiifrrr i i ni iTr.rTirri--------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- i»r i r n n i t r i t im r i r m \W f r i r r r  t r i i j '•‘r i <W M nw m ?w )^ t f : l~ 'u n M ir ‘ ‘ i i rrir »nifti npirmnniiriirg n r r r m i r —y ; n  vi ii n im m -¡i f i nn r " ' ‘h " 1 ‘ 11111 11 ~“ i n r n r .......... r u r  ‘f i n in .......in i.......................... ...........-i... ................................................................................................... ............ 1' * 1 .................................... ...................... .... ...........««■■»■»»»«**.. m n n t n .................. . » m i ............... ................................................................................ ........................................,WI>..........1 ......................... ........................................... ..................... .............
Diagnosis 0 1 2 3 4 5 6 7 8 >9
'm + v m W Hu ii« j>ipii ^ w >*^ >w w w wftw tafc,w ^ iw w ^ 4  w iw * -:i^ M H rt^ H M iiiiiu u p iiii>|ir*w<OHiWMi»<J j ^ w» r e i»rtxi)wwuM»Mtfj iM.iy h li* ^ i)'r^«rrH iiW<Mi»>mr;Hi: j ii j ™ f f l r iW W rffiiiii)rrmT«niM ^w^M«iiiiiw.u*i>.ij.ijjjjiii.M.jjt<<iWM' tfMu^ M M M w ^ iw wwMw^ H M ftWWwwfttwwwiwaM MMw»
%■ SD % SD SD % % SD SD % SD % SD SD*tyrrr r ik n to r^ % SD
.  u . h i i ~ i . i ^ . . i  . . . I  n  t  -*—
Complete mole without PGTD 2.7 1.3 23.9 5 . 4 50.6 7.2 13.5 3.6 6,5 2.8 1.5 LI 0.8 0.6 0.3 0.3 0.2 0.3 0.1 0.3
Complete mole with PGTD 3.5 2.2 23.0 6 . 4 50.0 9.5 13.7 3.6 6.5 3.1 1.6 1.6 0.7 0.9 0.4 0.6 0.3 0.4 0.2 0.5
Partial mole with PGTD 3.2 1.7 28,9 9.1 48.0 A Ö■^tvO 12.3 5.5 4.6 2.4 JL •** 0.8 0.9 1.0 0.4 0.6 0.2 0.3 ii ^ 0.5
...........— ---------------------- --------- r f T v.r^— ------- t^ . f,.irn ,,r ^ r r ^ ^ ^ r ^ ^ rn^ ñ r í^ r .i r ^ ^ i r .r ^fn i frr T || r r r ^ » TrJ^ t ^ .|fffv.1ÍJ^ r x,»r r ^ ,T ^ .n ..Tn,.„.1..r , ^ ^ rn.f¡[fi— ¡ììììrr‘,*‘T,Pì*fT^ 1i^ *11*1,^ **r* ^ *hrrgffttir^ Mrr*xffi'ivh*>i‘àgAa,^rta,^ ^fcTifHw^ "iTiîi*‘Alil‘jyrrffLfîlfa*aa'WA<iH>f‘‘,"!'aijr*‘T I^r ir i ftr*r "lìf ti*^r~iTTiri1^-ìfc:i1 c ìtiiit"! Tf.rrrrfr.T~n I rrr ii^ 'rviiirt^ i^'TTTr^ n^ Trìf òr i iirrt ^ ii*irtìir^ iì wi^  <TììJ'T]iy f iiT'inrì ìf nf ^~Mi^ ifi(ìjrì]'|j^Piìf f T‘*FrTTr~Ti~rriiTi:ff^ fffîf vfi~iìfi~jTiTriTiTTì~r^ f^‘fìf Fn^ j^nfcnrtiiii"iìriìi~f iii¡~^ ....
the cases were found to be DNA polyploid with a
high 2.5c and 5c ER, which are objective numerical, 
parameters for increased DNA content, but there
.JL *
was no in the height of the 
2.5c and 5c ER between CMs 'with or without PGTD.
Interphase cytogenetic performed on
paraffin-embedded tissues allows the detection of 
numerical chromosomal aberrations at the nuclear 
level with conservation of histologic morphology. 
Therefore, a more specific evaluation of the area of 
interest (extravillous trophoblast) is possible. Again,
rf™'* 'iW f  •'fctrvtfr
however, no correlation could be found between 
the occurrence of PGTD and the degree of numer­
ical chromosomal aberrations, neither with respect 
to the number of aberrant nuclei nor to the degree
of chromosomal aberrations the nucleus
Also, with this method, 'there will be an underesti-
of numerical chromo-mation of the real 
somal aberrations, because the nuclei are truncated
as a result of tissue sectioning. Therefore 
variations could be missed.
On the basis of these results, we conclude that in 
CMs the degree of nuclear atypia and correspond­
ing increase in DNA content is not correlated with 
PGTD. The mechanism of tumor progression in 
trophoblastic disease and somatic neoplasia, there­
fore, seems to be different, 
for these negative findings comes from experimen­
tal animal studies (27), from which it is known that 
during the formation of the placenta 
cles of placental bed trophoblastic giant cells are 
formed, with high DNA contents present as a result
occurs in the intermediate trophoblast at the pla­
cental implantation site, at which location tropho­
blast cells invade the uterus between decidual and 
myométrial cells. This giant cell transformation is
L  y  . - w  -
FIGURE 4. Interphase cytogenetic analysis on. 6-^m paraffin-
sections using a biotinylated DNA-profoe specific for
the pericentromeric region of chromosome 1. The extravillous 
trophoblast shows prominent nuclear atypia 'with polysomy, in contrast 
to the villous trophoblast and stromal, cells, which show disomy (upper 
right; counterstaining with Mayer's hematoxylin; original magnification;
300X).
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role in differentiating the low-risk PMs, which are 
DNA triploid, from the high-risk CMs or from high- 
risk (and incorrectly classified) PMs, which are DNA 
polyploid. In the latter group, the information de­
rived from these techniques has no additional pre­
dictive value in the development of PGTD. There­
fore, the mechanisms that play the decisive role in 
the progression of hydatidiform moles remain to be 
elucidated.
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